Thirty-day mortality, although relatively low, was still higher than for HIV-uninfected patients.
Now that HIV-infected individuals have a near-normal life expectancy, they are increasingly likely to undergo surgical procedures. How do their short-term surgical outcomes compare with those of HIV-uninfected patients?
To answer this question, investigators studied 30-day mortality among HIV-infected patients on antiretroviral therapy (ART) who underwent major inpatient surgery and procedure-matched, uninfected controls in the Veterans Aging Cohort Study Virtual Cohort (n=1641 and 3282, respectively). The HIV-infected cohort was primarily male (98.5%) with a median age of 54.3; 80.0% had a CD4 count ≥200 cells/mm3, and 74.1% had an undetectable viral load. The most common surgical procedures were cholecystectomy, hip arthroplasty, spine sur…
Reviewing Author
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)